Search

everythinglearnresearchcommunity

for

Search:↓

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Combination therapy is more effective for prostate volumes over 60 ml.

Procyanidins from grape seeds reduce nerve pain by blocking specific proteins and inflammation.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Using 5-butylpicolinate esters improves the sensitivity and reliability of detecting testosterone and dihydrotestosterone in saliva.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

Targeting the p300/AR axis may help treat polycystic ovary syndrome.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Including androgens in hormone therapy may lower breast cancer risk.

Androgen signaling reduces Wnt activity, affecting prostate stem cell growth.

Retinol acetate can reduce the harmful effects of the drug benoxaprofen on white blood cells.

Finasteride blocks progesterone's effect on brain activity linked to epilepsy.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

A new compound was effective for imaging prostate cancer in rats.

Progesterone-derived neurosteroids affect GABA-A receptor expression, influencing epilepsy during menstrual cycles.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

Different ligands change the shape of the TRPV3 ion channel in unique ways.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Estrogens can reduce DHT production in hair follicles, but are less effective than finasteride and progesterone.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Finasteride shows promise for preventing prostate cancer, but more research is needed.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.